<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>uremic toxins</title>
    <link>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1X9MO_201KJDQLcj05Nvzta1Id2nl8y7pss40102ZP6FDvbwfD&amp;utm_content=1X9MO_201KJDQLcj05Nvzta1Id2nl8y7pss40102ZP6FDvbwfD&amp;utm_medium=rss&amp;utm_source=Wget&amp;v=2.17.9.post6+86293ac&amp;fc=20230504143725&amp;utm_campaign=pubmed-2&amp;ff=20230504191819</link>
    <description>uremic toxins: Latest results from PubMed</description>
    <atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1X9MO_201KJDQLcj05Nvzta1Id2nl8y7pss40102ZP6FDvbwfD&amp;utm_content=1X9MO_201KJDQLcj05Nvzta1Id2nl8y7pss40102ZP6FDvbwfD&amp;utm_medium=rss&amp;utm_source=Wget&amp;v=2.17.9.post6+86293ac&amp;fc=20230504143725&amp;utm_campaign=pubmed-2&amp;ff=20230504191819" rel="self"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
    <language>en</language>
    <lastBuildDate>Thu, 04 May 2023 23:18:19 +0000</lastBuildDate>
    <pubDate>Tue, 29 Jun 2021 06:00:00 -0400</pubDate>
    <ttl>120</ttl>
    <item>
      <title>Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34183248/?utm_source=Wget&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1X9MO_201KJDQLcj05Nvzta1Id2nl8y7pss40102ZP6FDvbwfD&amp;fc=20230504143725&amp;ff=20230504191819&amp;v=2.17.9.post6+86293ac</link>
      <description>CONCLUSIONS: Albumins isolated from individuals with T2DM and eGFR&lt;60mL/min/1.73m² suffer greater carbamoylation, and they impair the cholesterol efflux mediated by HDL(2) and HDL(3). In turn, this could promote lipids accumulation in macrophages and disorders in reverse cholesterol transport.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Diabetes Complications. 2021 Sep;35(9):107969. doi: 10.1016/j.jdiacomp.2021.107969. Epub 2021 May 28.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Abnormalities in lipid metabolism, accumulation of uremic toxins and advanced glycation end products may contribute to worsening atherosclerosis. This study characterized the glycation and carbamoylation profile of serum albumin isolated from individuals with diabetic kidney disease and its influence on cholesterol efflux.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MATERIAL AND METHODS: 49 patients with type 2 diabetes (T2DM) and different eGFR evaluated glycation and carbamoylation profile by measurement of carboxymethyl lysine (CML) and carbamoylated proteins (CBL) in plasma by ELISA, homocitrulline (HCit) in plasma by colorimetry. In the isolated albumins, we quantified CBL (ELISA) and total AGE and pentosidine by fluorescence. Macrophages were treated with albumin isolated, and <sup>14</sup>C-Cholesterol efflux mediated by HDL<sub>2</sub> or HDL<sub>3</sub> was measured. Kruskal-Wallis test, Jonckheere-Terpstra test and Brunner's posttest were used for comparisons among groups.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Determination of CML, HCit, CBL in plasma, as total AGE and pentosidine in albumins, did not differ between groups; however, CBL in the isolated albumins was higher in the more advanced stages of CKD (p=0.0414). There was reduction in the <sup>14</sup>C-cholesterol efflux after treatment for 18h with albumin isolated from patients with eGFR&lt;60mL/min/1.73m<sup>2</sup> compared with control group mediated by HDL<sub>2</sub> (p=0.0288) and HDL<sub>3</sub> (p&lt;0.0001), as well as when compared with eGFR ≥60mL/min/1.73m<sup>2</sup> per HDL<sub>2</sub> (p=0.0001) and HDL<sub>3</sub> (p&lt;0.0001). Treatment for 48h showed that eGFR&lt;15mL/min/1.73m<sup>2</sup> had a lower percentage of <sup>14</sup>C-cholesterol efflux mediated by HDL<sub>2</sub> compared to control and other CKD groups (p=0.0274).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Albumins isolated from individuals with T2DM and eGFR&lt;60mL/min/1.73m<sup>2</sup> suffer greater carbamoylation, and they impair the cholesterol efflux mediated by HDL<sub>2</sub> and HDL<sub>3</sub>. In turn, this could promote lipids accumulation in macrophages and disorders in reverse cholesterol transport.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34183248/?utm_source=Wget&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1X9MO_201KJDQLcj05Nvzta1Id2nl8y7pss40102ZP6FDvbwfD&fc=20230504143725&ff=20230504191819&v=2.17.9.post6+86293ac">34183248</a> | DOI:<a href=https://doi.org/10.1016/j.jdiacomp.2021.107969>10.1016/j.jdiacomp.2021.107969</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34183248</guid>
      <pubDate>Tue, 29 Jun 2021 06:00:00 -0400</pubDate>
      <dc:creator>Aécio Lopes de Araújo Lira</dc:creator>
      <dc:creator>Monique de Fátima Mello Santana</dc:creator>
      <dc:creator>Raphael de Souza Pinto</dc:creator>
      <dc:creator>Carlos André Minanni</dc:creator>
      <dc:creator>Rodrigo Tallada Iborra</dc:creator>
      <dc:creator>Adriana Machado Saldiba de Lima</dc:creator>
      <dc:creator>Maria Lúcia Correa-Giannella</dc:creator>
      <dc:creator>Marisa Passarelli</dc:creator>
      <dc:creator>Márcia Silva Queiroz</dc:creator>
      <dc:date>2021-06-29</dc:date>
      <dc:source>Journal of diabetes and its complications</dc:source>
      <dc:title>Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease</dc:title>
      <dc:identifier>pmid:34183248</dc:identifier>
      <dc:identifier>doi:10.1016/j.jdiacomp.2021.107969</dc:identifier>
    </item>
    <item>
      <title>Carbamoylation of amino acids and proteins in uremia</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/11168993/?utm_source=Wget&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1X9MO_201KJDQLcj05Nvzta1Id2nl8y7pss40102ZP6FDvbwfD&amp;fc=20230504143725&amp;ff=20230504191819&amp;v=2.17.9.post6+86293ac</link>
      <description>Cyanate spontaneously transformed from urea increases as renal function decreased. Acting as a potential toxin, the active form of cyanate, isocyanic acid, carbamoylates amino acids, proteins, and other molecules, changing their structure, charge, and function. The resulting in vivo carbamoylation can modify the molecular activity of enzymes, cofactors, hormones, low-density lipoproteins, antibodies, receptors, and transport proteins. Antibodies specific for epsilon-amino-carbamoyl-lysine...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Kidney Int Suppl. 2001 Feb;78:S102-7. doi: 10.1046/j.1523-1755.2001.59780102.x.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cyanate spontaneously transformed from urea increases as renal function decreased. Acting as a potential toxin, the active form of cyanate, isocyanic acid, carbamoylates amino acids, proteins, and other molecules, changing their structure, charge, and function. The resulting in vivo carbamoylation can modify the molecular activity of enzymes, cofactors, hormones, low-density lipoproteins, antibodies, receptors, and transport proteins. Antibodies specific for epsilon-amino-carbamoyl-lysine (homocitrulline) located carbamoylated proteins in situ in neutrophils, monocytes, and erythrocytes. Carbamoylated proteins were found in renal tissue from uremic patients but not in normal transplanted kidneys. The irreversible reaction with cyanate converts free amino acids (F-AAs) to carbamoyl-amino acids (C-AAs). The Carbamoylation Index (CI), C-AA/F-AA, quantifies the decrease of the F-AA pool for each essential amino acid. C-AAs contribute, in part, to malnutrition of uremia. C-AAs interfered with protein synthesis to lower 14C hemoglobin synthesis in human reticulocytes and osteocalcin synthesis in rat osteosarcoma-derived tissue culture. Insulin-sensitive glucose uptake was decreased 33% in cultured rat adipocytes by alpha-amino-carbamoyl-asparagine. alpha-Amino carbamoylation occurs primarily in F-AA, while epsilon-amino carbamoylation of lysine in protein occurs continuously during the protein life span. Protein catabolism releases epsilon-amino-carbamoyl-lysine. Quantitation of alpha versus epsilon carbamoylation may yield a more sensitive measurement of protein intake versus protein catabolism, and could be useful in decisions concerning the time to initiate dialysis or subsequent changes in dialysis prescription. Carbamoylated molecules can block, enhance, or be excluded from metabolic pathways, thereby influencing the fate of noncarbamoylated molecules. Although not an "all-or-none" phenomenon, urea-derived cyanate and its actions are contributing causes of toxicity in uremia.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/11168993/?utm_source=Wget&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1X9MO_201KJDQLcj05Nvzta1Id2nl8y7pss40102ZP6FDvbwfD&fc=20230504143725&ff=20230504191819&v=2.17.9.post6+86293ac">11168993</a> | DOI:<a href=https://doi.org/10.1046/j.1523-1755.2001.59780102.x>10.1046/j.1523-1755.2001.59780102.x</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:11168993</guid>
      <pubDate>Tue, 13 Feb 2001 06:00:00 -0500</pubDate>
      <dc:creator>L M Kraus</dc:creator>
      <dc:creator>A P Kraus</dc:creator>
      <dc:date>2001-02-13</dc:date>
      <dc:source>Kidney international. Supplement</dc:source>
      <dc:title>Carbamoylation of amino acids and proteins in uremia</dc:title>
      <dc:identifier>pmid:11168993</dc:identifier>
      <dc:identifier>doi:10.1046/j.1523-1755.2001.59780102.x</dc:identifier>
    </item>
    <item>
      <title>The search for the uremic toxin: the case for carbamoylation of amino acids and proteins</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/9782570/?utm_source=Wget&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1X9MO_201KJDQLcj05Nvzta1Id2nl8y7pss40102ZP6FDvbwfD&amp;fc=20230504143725&amp;ff=20230504191819&amp;v=2.17.9.post6+86293ac</link>
      <description>Urea and cyanate, spontaneously transformed from urea, are increased with decreased renal function becoming potential toxins. Isocyanic acid, the active form of cyanate, carbamoylates proteins, amino acids and other molecules, changing molecular structure and function in vivo. Carbamoylation can occur at multiple sites with a cumulative effect over the the life-span of the molecule. Carbamoylation converts free amino acids to carbamoyl-amino acids (C-AA). C-AA interfere with protein synthesis...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Wien Klin Wochenschr. 1998 Aug 21;110(15):521-30.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Urea and cyanate, spontaneously transformed from urea, are increased with decreased renal function becoming potential toxins. Isocyanic acid, the active form of cyanate, carbamoylates proteins, amino acids and other molecules, changing molecular structure and function in vivo. Carbamoylation can occur at multiple sites with a cumulative effect over the the life-span of the molecule. Carbamoylation converts free amino acids to carbamoyl-amino acids (C-AA). C-AA interfere with protein synthesis and transamination reactions and contribute, in part, to protein-malnutrition. Insulin-sensitive glucose uptake is decreased by carbamoyl-asparagine. Cyanate inhibits superoxide release from neutrophils to an extent that interferes with microbiocidal activity. Antihomocitrulline antibodies identified homocitrulline (epsilon-amino-carbamoyl lysine) in situ in proteins in neutrophils in end stage renal disease. Also in uremic patients, homocitrulline was located in proteins in renal tissue but was not found in normal transplanted kidneys. Carbamoylated human low density lipoprotein interferes with human receptor binding, has decreased clearance, and is auto-immunogenic in animals. Carbamoylated insulin has decreased biological activity and changed immunological reactivity. Carbamoylation at a site of molecular activity can affect molecular function of enzymes, co-enzymes, antibodies, hormones and receptors. Carbamoyl-molecules can block, enhance, or be excluded from metabolic pathways, and can affect binding and trafficking, thereby influencing the fate of non-carbamoylated molecules. Normal renal function removes C-AA. In uremia, C-AA are removed by residual renal function or dialysis. Toxicity of cyanate is not an "all or none" phenomenon, but the actions of cyanate are a contributing factor in uremia. Removal of urea, cyanate and carbamoyl-molecules partially alleviates the morbidity and mortality of renal disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/9782570/?utm_source=Wget&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1X9MO_201KJDQLcj05Nvzta1Id2nl8y7pss40102ZP6FDvbwfD&fc=20230504143725&ff=20230504191819&v=2.17.9.post6+86293ac">9782570</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:9782570</guid>
      <pubDate>Fri, 23 Oct 1998 06:00:00 -0400</pubDate>
      <dc:creator>L M Kraus</dc:creator>
      <dc:creator>A P Kraus</dc:creator>
      <dc:date>1998-10-23</dc:date>
      <dc:source>Wiener klinische Wochenschrift</dc:source>
      <dc:title>The search for the uremic toxin: the case for carbamoylation of amino acids and proteins</dc:title>
      <dc:identifier>pmid:9782570</dc:identifier>
    </item>
  </channel>
</rss>
